Table of Contents
Journal of Signal Transduction
Volume 2012 (2012), Article ID 804801, 7 pages
http://dx.doi.org/10.1155/2012/804801
Research Article

Effects of Somatic Mutations in the C-Terminus of Insulin-Like Growth Factor 1 Receptor on Activity and Signaling

Department of Physiology and Biophysics, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA

Received 7 March 2012; Accepted 28 April 2012

Academic Editor: A. Yoshimura

Copyright © 2012 Barbara P. Craddock and W. Todd Miller. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Manning, D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, “The protein kinase complement of the human genome,” Science, vol. 298, no. 5600, pp. 1912–1934, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. P. A. Futreal, L. Coin, M. Marshall et al., “A census of human cancer genes,” Nature Reviews Cancer, vol. 4, no. 3, pp. 177–183, 2004. View at Google Scholar · View at Scopus
  3. P. Blume-Jensen and T. Hunter, “Oncogenic kinase signalling,” Nature, vol. 411, no. 6835, pp. 355–365, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. T. E. Adams, V. C. Epa, T. P. J. Garrett, and C. W. Ward, “Structure and function of the type 1 insulin-like growth factor receptor,” Cellular and Molecular Life Sciences, vol. 57, no. 7, pp. 1050–1093, 2000. View at Google Scholar · View at Scopus
  5. H. Kato, T. N. Faria, B. Stannard, C. T. Roberts, and D. LeRoith, “Role of tyrosine kinase activity in signal transduction by the insulin- like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (αIR-3),” The Journal of Biological Chemistry, vol. 268, no. 4, pp. 2655–2661, 1993. View at Google Scholar · View at Scopus
  6. S. Favelyukis, J. H. Till, S. R. Hubbard, and W. T. Miller, “Structure and autoregulation of the insulin-like growth factor 1 receptor kinase,” Nature Structural Biology, vol. 8, no. 12, pp. 1058–1063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Munshi, M. Kornienko, D. L. Hall et al., “Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase implication for inhibitor specificity,” The Journal of Biological Chemistry, vol. 277, no. 41, pp. 38797–38802, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Pautsch, A. Zoephel, H. Ahorn, W. Spevak, R. Hauptmann, and H. Nar, “Crystal structure of bisphosphorylated igf-1 receptor kinase: insight into domain movements upon kinase activation,” Structure, vol. 9, no. 10, pp. 955–965, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. B. P. Craddock, C. Cotter, and W. T. Miller, “Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region,” FEBS Letters, vol. 581, no. 17, pp. 3235–3240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Baserga, F. Peruzzi, and K. Reiss, “The IGF-1 receptor in cancer biology,” International Journal of Cancer, vol. 107, no. 6, pp. 873–877, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Hartog, J. Wesseling, H. M. Boezen, and W. T. A. van der Graaf, “The insulin-like growth factor 1 receptor in cancer: old focus, new future,” European Journal of Cancer, vol. 43, no. 13, pp. 1895–1904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Pollak, “Insulin and insulin-like growth factor signalling in neoplasia,” Nature Reviews Cancer, vol. 8, no. 12, pp. 915–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Baserga, A. Hongo, M. Rubini, M. Prisco, and B. Valentinis, “The IGF-I receptor in cell growth, transformation and apoptosis,” Biochimica et Biophysica Acta, vol. 1332, no. 3, pp. F105–F126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Werner, M. Shalita-Chesner, S. Abramovitch, G. Idelman, L. Shaharabani-Gargir, and T. Glaser, “Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer,” Molecular Genetics and Metabolism, vol. 71, no. 1-2, pp. 315–320, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Sakatani, A. Kaneda, C. A. Iacobuzio-Donahue et al., “Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice,” Science, vol. 307, no. 5717, pp. 1976–1978, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Greenman, P. Stephens, R. Smith et al., “Patterns of somatic mutation in human cancer genomes,” Nature, vol. 446, no. 7132, pp. 153–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Ding, G. Getz, D. A. Wheeler et al., “Somatic mutations affect key pathways in lung adenocarcinoma,” Nature, vol. 455, no. 7216, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Sell, M. Rubini, R. Rubin, J. P. Liu, A. Efstratiadis, and R. Baserga, “Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11217–11221, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. S. C. Barker, D. B. Kassel, D. Weigl, X. Huang, M. A. Luther, and W. B. Knight, “Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process,” Biochemistry, vol. 34, no. 45, pp. 14843–14851, 1995. View at Google Scholar · View at Scopus
  20. S. E. Shoelson, S. Chatterjee, M. Chaudhuri, and M. F. White, “YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2027–2031, 1992. View at Google Scholar · View at Scopus
  21. W. Li and W. T. Miller, “Role of the activation loop tyrosines in regulation of the insulin-like growth factor I receptor-tyrosine kinase,” The Journal of Biological Chemistry, vol. 281, no. 33, pp. 23785–23791, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. White and L. Yenush, “The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action,” Current Topics in Microbiology and Immunology, vol. 228, pp. 179–208, 1997. View at Google Scholar · View at Scopus
  23. B. Valentinis and R. Baserga, “IGF-I receptor signalling in transformation and differentiation,” Journal of Clinical Pathology, vol. 54, no. 3, pp. 133–137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. X. J. Sun, P. Rothenberg, C. R. Kahn et al., “Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein,” Nature, vol. 352, no. 6330, pp. 73–77, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. P. A. Kiely, A. Sant, and R. O'Connor, “RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death,” The Journal of Biological Chemistry, vol. 277, no. 25, pp. 22581–22589, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Akiyama, S. Matsuda, Y. Namba, T. Saito, K. Toyoshima, and T. Yamamoto, “The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain,” Molecular and Cellular Biology, vol. 11, no. 2, pp. 833–842, 1991. View at Google Scholar · View at Scopus
  27. F. Chiara, S. Bishayee, C. H. Heldin, and J. B. Demoulin, “Autoinhibition of the platelet-derived growth factor beta-receptor tyrosine kinase by its C-terminal tail,” The Journal of Biological Chemistry, vol. 279, no. 19, pp. 19732–19738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. Shewchuk, A. M. Hassell, B. Ellis et al., “Structure of the Tie2 RTK domain—self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail,” Structure, vol. 8, no. 11, pp. 1105–1113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. X. L. Niu, K. G. Peters, and C. D. Kontos, “Deletion of the carboxyl terminus of Tie2 enhances kinase activity, signaling, and function: evidence for an autoinhibitory mechanism,” The Journal of Biological Chemistry, vol. 277, no. 35, pp. 31768–31773, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Frankel, S. M. Bishop, A. J. Ablooglu, Y. P. Han, and R. A. Kohanski, “Conformational changes in the activation loop of the insulin receptor's kinase domain,” Protein Science, vol. 8, no. 10, pp. 2158–2165, 1999. View at Google Scholar · View at Scopus
  31. B. Sehat, S. Andersson, R. Vasilcanu, L. Girnita, and O. Larsson, “Role of ubiquitination in IGF-1 receptor signaling and degradation,” PLoS ONE, vol. 2, no. 4, article e340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Tartare, I. Mothe, A. Kowalski-Chauvel, J. P. Breittmayer, R. Ballotti, and E. Van Obberghen, “Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor,” The Journal of Biological Chemistry, vol. 269, no. 15, pp. 11449–11455, 1994. View at Google Scholar · View at Scopus
  33. S. M. Najjar, V. A. Blakesley, S. Li Calzi, H. Kato, D. LeRoith, and C. V. Choice, “Differential phosphorylation of pp120 by insulin and insulin-like growth factor-I receptors: role for the C-terminal domain of the β-subunit,” Biochemistry, vol. 36, no. 22, pp. 6827–6834, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. R. W. Furlanetto, B. R. Dey, W. Lopaczynski, and S. P. Nissley, “14-3-3 Proteins interact with the insulin-like growth factor receptor but not the insulin receptor,” Biochemical Journal, vol. 327, no. 3, pp. 765–771, 1997. View at Google Scholar · View at Scopus
  35. T. Ligensa, S. Krauss, D. Demuth et al., “A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor,” The Journal of Biological Chemistry, vol. 276, no. 36, pp. 33419–33427, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Liu, S. Lehar, C. Corvi, G. Payne, and R. O'Connor, “Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells,” Cancer Research, vol. 58, no. 3, pp. 570–576, 1998. View at Google Scholar · View at Scopus
  37. A. Hongo, G. Yumet, M. Resnicoff, G. Romano, R. O'Connor, and R. Baserga, “Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor,” Cancer Research, vol. 58, no. 11, pp. 2477–2484, 1998. View at Google Scholar · View at Scopus
  38. K. Reiss, G. Yumet, S. Shan et al., “Synthetic peptide sequence from the C-terminus of the insulin-like growth factor-I receptor that induces apoptosis and inhibition of tumor growth,” Journal of Cellular Physiology, vol. 181, no. 1, pp. 124–135, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. R. O'Connor, A. Kauffmann-Zeh, Y. Liu et al., “Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis,” Molecular and Cellular Biology, vol. 17, no. 1, pp. 427–435, 1997. View at Google Scholar · View at Scopus
  40. A. Hongo, C. D'Ambrosio, M. Miura, A. Morrione, and R. Baserga, “Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor,” Oncogene, vol. 12, no. 6, pp. 1231–1238, 1996. View at Google Scholar · View at Scopus